NFKB1 and colitis: Extensive studies have indicated that the transcription factor NF-κB plays a crucial role in regulating the intestinal TJ barrier function and increased permeability in vitro and in animal models of colitis [30, 33, 49–53], and inhibition of NF-κB signaling improved symptoms of DSS-induced colitis in mice [54, 55].